Drug Shortage Report for ACT PIOGLITAZONE
Report ID | 137882 |
Drug Identification Number | 02302861 |
Brand name | ACT PIOGLITAZONE |
Common or Proper name | PIOGLITAZONE 15MG TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | PIOGLITAZONE |
Strength(s) | 15MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | A10BG |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2021-04-20 |
Estimated end date | |
Actual end date | 2022-04-27 |
Shortage status | Resolved |
Updated date | 2022-04-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2022-04-28 | French | Compare |
v11 | 2022-04-28 | English | Compare |
v10 | 2021-10-14 | French | Compare |
v9 | 2021-10-14 | English | Compare |
v8 | 2021-05-20 | French | Compare |
v7 | 2021-05-20 | English | Compare |
v6 | 2021-05-10 | French | Compare |
v5 | 2021-05-10 | English | Compare |
v4 | 2021-04-29 | French | Compare |
v3 | 2021-04-29 | English | Compare |
v2 | 2021-04-21 | French | Compare |
v1 | 2021-04-21 | English | Compare |
Showing 1 to 12 of 12